Atlas Trials

Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung

Clinical trial NCT05228795 · UNKNOWN

Trial details

NCT number
NCT05228795
Sponsor
Sohag University
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Cancer AdenocarcinomaLung Cancer Squamous CellMesothelioma; Lung
Start date
2022-02-01
Primary completion
2022-06-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.